Offer - Urjas Oil for just ₹ 1 X
Nolasma is an allopathic medicine The correct dosage of Nolasma depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Nolasma is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nolasma safe for pregnant women?
Nolasma may have some side effects during pregnancy. Pregnant women should discontinue the use of Nolasma, and talk to their doctor, if they notice any discomfort.
Is the use of Nolasma safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Nolasma. It should only be taken after medical advice.
What is the effect of Nolasma on the Kidneys?
There is no research available on the side effects of Nolasma on kidney. Therefore, its impact is unknown.
What is the effect of Nolasma on the Liver?
Nolasma can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Nolasma on the Heart?
Nolasma is not harmful for the heart.
Nolasma should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Nolasma unless your doctor advises you to do so -
Is this Nolasma habit forming or addictive?
Nolasma does not cause addiction.
Interaction between Food and Nolasma
Taking Nolasma with food is safe.
Interaction between Alcohol and Nolasma
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Nolasma.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 288
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cortef® (hydrocortisone)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Solu-Cortef® (hydrocortisone sodium succinate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pandel (hydrocortisone probutate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cortenema® (hydrocortisone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 892
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tri-luma® (fluocinolone acetonide, hydroquinone and tretinoin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 718-719
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A Micro (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retin-A® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renova® (tretinoin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vesanoid® (tretinoin)